cyc 202 has been researched along with alsterpaullone in 10 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (alsterpaullone) | Trials (alsterpaullone) | Recent Studies (post-2010) (alsterpaullone) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 80 | 0 | 31 |
| Protein | Taxonomy | cyc 202 (IC50) | alsterpaullone (IC50) |
|---|---|---|---|
| Chain A, Glycogen Synthase Kinase-3 Beta | Homo sapiens (human) | 0.004 | |
| Chain B, Glycogen Synthase Kinase-3 Beta | Homo sapiens (human) | 0.004 | |
| Chain A, Glycogen Synthase Kinase-3 Beta | Homo sapiens (human) | 0.004 | |
| G2/mitotic-specific cyclin-B2 | Homo sapiens (human) | 0.035 | |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | 0.0321 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 1.5 | |
| G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | 0.035 | |
| G2/mitotic-specific cyclin-B | Marthasterias glacialis (spiny starfish) | 0.0263 | |
| Glycogen synthase kinase-3 beta | Rattus norvegicus (Norway rat) | 0.0263 | |
| Cyclin-A2 | Homo sapiens (human) | 0.015 | |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | 0.015 | |
| Glycogen synthase kinase-3 alpha | Homo sapiens (human) | 0.0043 | |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | 0.0105 | |
| Cyclin-dependent-like kinase 5 | Homo sapiens (human) | 0.0608 | |
| Cyclin-dependent kinase 5 activator 1 | Homo sapiens (human) | 0.0815 | |
| G2/mitotic-specific cyclin-B3 | Homo sapiens (human) | 0.035 | |
| Cyclin-dependent kinase 1 | Oryzias latipes (Japanese medaka) | 0.0263 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benfield, PA; Boylan, JF; Sielecki, TM; Trainor, GL | 1 |
| Bhattacharjee, AK; Ellis, W; Gerena, L; Geyer, JA; Kathcart, AK; Kyle, DE; Li, Z; Lopez-Sanchez, M; Nichols, DA; Prigge, ST; Terrell, J; Waters, NC; Woodard, CL | 1 |
| Akula, N; Pattabiraman, N; Sridhar, J | 1 |
| Alessi, DR; Arthur, JS; Bain, J; Cohen, P; Elliott, M; Hastie, CJ; Klevernic, I; McLauchlan, H; Plater, L; Shpiro, N | 1 |
| Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Baek, NI; Cho, JG; Jeon, YJ; Kim, GS; Lee, DY; Natarajan, S; Park, JH; Shrestha, S; Yang, DC; Yeon, SW | 1 |
| Bharate, SB; Raghuvanshi, R | 1 |
| Caballero, E; García-Cárceles, J; Gil, C; Martínez, A | 1 |
| Belachew, S; Hans, G; Malgrange, B; Moonen, G; Nguyen, L; Rigo, JM; Rocher, V | 1 |
3 review(s) available for cyc 202 and alsterpaullone
| Article | Year |
|---|---|
Cyclin-dependent kinase inhibitors: useful targets in cell cycle regulation.
Topics: Animals; Cell Cycle; Cyclin-Dependent Kinases; Enzyme Inhibitors; Humans; Models, Molecular | 2000 |
Selectivity and potency of cyclin-dependent kinase inhibitors.
Topics: Animals; Binding Sites; Cyclin-Dependent Kinases; Humans; Protein Kinase Inhibitors; Signal Transduction | 2006 |
Kinase Inhibitors as Underexplored Antiviral Agents.
Topics: Animals; Antiviral Agents; Drug Repositioning; Humans; Protein Kinase Inhibitors; Virus Diseases; Viruses | 2022 |
7 other study(ies) available for cyc 202 and alsterpaullone
| Article | Year |
|---|---|
Oxindole-based compounds are selective inhibitors of Plasmodium falciparum cyclin dependent protein kinases.
Topics: Amino Acid Sequence; Animals; Antimalarials; Cyclin-Dependent Kinase-Activating Kinase; Cyclin-Dependent Kinases; Enzyme Inhibitors; Humans; Indoles; Models, Molecular; Molecular Sequence Data; Plasmodium falciparum; Structure-Activity Relationship | 2003 |
The selectivity of protein kinase inhibitors: a further update.
Topics: Amino Acid Sequence; Animals; Cell Line; Drug Design; Enzyme Activation; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Recombinant Proteins; Spodoptera | 2007 |
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Potential neuroprotective flavonoid-based inhibitors of CDK5/p25 from Rhus parviflora.
Topics: Cyclin-Dependent Kinase 5; Flavonoids; Humans; Models, Molecular; Molecular Structure; Nerve Tissue Proteins; Neuroprotective Agents; Rhus | 2013 |
Recent Developments in the Use of Kinase Inhibitors for Management of Viral Infections.
Topics: Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Drug Approval; Drug Repositioning; High-Throughput Screening Assays; Humans; Protein Kinase Inhibitors; SARS-CoV-2; United States; United States Food and Drug Administration; Virus Diseases | 2022 |
Chemical inhibitors of cyclin-dependent kinases control proliferation, apoptosis and differentiation of oligodendroglial cells.
Topics: Animals; Animals, Newborn; Apoptosis; Benzazepines; Cell Differentiation; Cell Division; Cells, Cultured; Cerebral Cortex; Cyclin-Dependent Kinases; Enzyme Activation; Indoles; Oligodendroglia; Purines; Rats; Roscovitine | 2003 |